US and UK agree zero-tariffs on pharmaceuticals

Group 1 - The US has agreed to exempt the UK from potential trade tariffs on pharmaceutical products, ensuring UK citizens have access to the latest pharmaceutical breakthroughs [1] - The agreement follows months of uncertainty regarding the imposition of steep charges on UK exports and is part of a broader effort to improve the operating environment for firms in Britain [2] - Concerns have been raised that the pricing regime prioritizing low costs for the NHS may hinder revenue for firms and discourage investment in the UK pharmaceutical market [2] Group 2 - The UK science minister indicated that many drugs available in the UK are likely to experience "inevitable" price increases as negotiations with the US continue [3]